Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2019 16:15 ET | Source: Liquidia Technologies, Inc.

Liquidia and GSK Restructure Collaboration Agreement

RESEARCH TRIANGLE PARK, N.C., June 26, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia” or the “Company”), a late-stage clinical biopharmaceutical company focused on...
June 05, 2019 16:05 ET | Source: Liquidia Technologies, Inc.

Liquidia Announces Clinical Update on INSPIRE; Targeting NDA Filing for LIQ861 in Late 2019

RESEARCH TRIANGLE PARK, N.C., June 05, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company, today provided an update on...
June 03, 2019 08:30 ET | Source: Liquidia Technologies, Inc.

Liquidia to Present at Jefferies Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., June 03, 2019 (GLOBE NEWSWIRE) -- LQDA) (“Liquidia”)">Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company, announced...
May 22, 2019 16:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Appoints Seasoned Biopharmaceutical Industry Executive Dr. Richard Katz as Chief Financial Officer

RESEARCH TRIANGLE PARK, N.C., May 22, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company, today announced the...
May 14, 2019 16:15 ET | Source: Liquidia Technologies, Inc.

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) International Conference 2019

RESEARCH TRIANGLE PARK, N.C., May 14, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company, today announced that Nicholas...
May 02, 2019 07:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Reports First Quarter 2019 Financial Results and Provides Corporate Update

Recent Phase 3 Data Highlight Clinical Relevance of LIQ861 in Treating Pulmonary Arterial HypertensionOn Track for Planned New Drug Application (NDA) Submission for LIQ861 in Late 2019Continued...
April 23, 2019 16:05 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies to Report First Quarter 2019 Financial Results and Provide Corporate Update on May 2, 2019

RESEARCH TRIANGLE PARK, N.C., April 23, 2019 (GLOBE NEWSWIRE) -- LQDA) (“Liquidia”),">Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused...
April 03, 2019 16:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Presents Phase 3 Trial Data for LIQ861 at the ISHLT 39th Annual Meeting & Scientific Sessions

RESEARCH TRIANGLE PARK, N.C., April 03, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development...
April 02, 2019 08:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies to Present at Needham Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., April 02, 2019 (GLOBE NEWSWIRE) -- LQDA) (“Liquidia”)">Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused...
March 25, 2019 10:54 ET | Source: Liquidia Technologies, Inc.

Liquidia Technologies Announces Closing of Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C., March 25, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development...